Lane Michael sold 242.944 shares of IDEXX LABORATORIES INC DE at $687.85 for −$167k on Nov 4, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Executive Vice President
Executive Vice President
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$167,109.03Shares × reported price
Shares traded
242.944Common Stock
Price per share
$687.85Reported price. Read footnotes for ranges.
% of reported position traded
3.02%This security and ownership context
Holdings after
7,812Direct
Trade date
Nov 4, 2026Sell
Filed
Nov 5, 2026, 5:01 PM ET1-day reporting delay
Accession
0000874716-26-000143Code S · Transaction 393698
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 8,054.944 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Sell2,059$689.70−$1,420,092.30Trade 393699
Nov 4, 2026Sell1,677$687.46−$1,152,868.07Trade 393700
3 transaction rows in this filing. Joint filers share the same rows.

IDXX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IDXX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −6.4%1w ago 0%1d ago 0%
Returns since7d +24%30d90d180d1y

Footnotes in full

F1: Includes a total of 31 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2026, June 30, 2026 and September 30, 2026. F2: Represents the weighted average price of the shares sold ranging from a low of $687.0701 to a high of $687.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F3: Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.